EUVIMEDEUVIMED entdecken
Crossref

Formulation development and optimization of sparfloxacin-loaded solid lipid nanoparticles integrated with microneedles for the treatment of biofilm-infected wounds

Jianmin Chen, Wanhui Wu, Baozhu Feng, Meilian Ning, Ziyan Cai, Qiulong Zhang, Liyang Du, Yunhua Gao

European Journal of Pharmaceutics and Biopharmaceutics · 2026

DOI: 10.1016/j.ejpb.2026.115181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Jianmin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Medical Technology, Putian University, Fujian, China; Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine (Putia…. Hauptthemen laut MEDLINE: Fluoroquinolones, Biofilms, Nanoparticles, Anti-Bacterial Agents. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Fujian Provincial Natural Science Foundation, Putian University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficient management of infected skin wounds is severely limited by the thick bacterial biofilm within the lesion, the intractable stratum corneum barrier of the perilesional skin, and the high toxicities of potent antibiotics. Sparfloxacin (SPFX) was withdrawn from the market due to its severe systemic side effects and UV-induced phototoxicity, while its severe hydrophobicity causes localized crystalline cytotoxicity upon topical application. To safely rejuvenate this potent drug, an integrated transdermal system combining photoshielding, SPFX-loaded solid lipid nanoparticles (SPFX-SLNs) with dissolving microneedles (MNs) was developed. This study primarily focuses on the systematic screening, formulation development, and optimization of SPFX-SLNs via Box-Behnken Design-Response Surface Methodology (BBD-RSM). The optimized nanocarriers exhibited a uniform size (86.85 ± 1.89 nm) and a two-fold higher antibacterial potency against Escherichia coli (E. coli) than free SPFX. Mechanistically, the solid lipid core locked SPFX in a safe amorphous state to preclude crystal-induced irritation, while functioning as a physical photoshield against UV activation. By depositing the nanomedicine exclusively into infected dermis, the MN platform minimized systemic drug exposure. In a rat model of E. coli-infected biofilm wounds, the formulated SPFX-SLNs MNs achieved over 50% (58.44%) wound closure within 3 days and near-complete re-epithelialization by day 11, and a 98.61% final closure rate by day 14. Ultimately, this work establishes a comprehensive formulation development strategy for a safety-enhanced, biofilm-penetrable nanomedicine-MN hybrid that successfully repurposes a clinically restricted antibiotic for advanced wound regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoroquinolonesBiofilmsNanoparticlesAnti-Bacterial AgentsLipidsWound InfectionAnimalsMicroneedle Drug DeliveryRatsEscherichia coliWound HealingMaleDrug CompoundingAdministration, CutaneousRats, Sprague-DawleySkinChemistry, PharmaceuticalLiposomes

Stichwörter der Autor:innen

Biofilm-infected woundsDissolving microneedlesFormulation optimizationSolid lipid nanoparticlesSparfloxacin

Substanzen

FluoroquinolonessparfloxacinAnti-Bacterial AgentsLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • School of Pharmacy and Medical Technology, Putian University, Fujian, China; Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine (Putian University), Fujian Province University, Fujian, China. Electronic a…
  • School of Pharmacy and Medical Technology, Putian University, Fujian, China.
  • School of Pharmacy and Medical Technology, Putian University, Fujian, China; Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine (Putian University), Fujian Province University, Fujian, China.
  • School of Pharmacy and Medical Technology, Putian University, Fujian, China; Key Laboratory of Medical Microecology (Putian University), Fujian Province University, Fujian, China. Electronic address: duliyang1995@163.co…
  • Beijing CAS Microneedle Technology Ltd, Beijing 102609, China. Electronic address: yhgao@mail.ipc.ac.cn.

Förderung

  • Fujian Provincial Natural Science Foundation
  • Putian University
  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Wu, W., Feng, B., Ning, M., Cai, Z., Zhang, Q., Du, L., & Gao, Y. (2026). Formulation development and optimization of sparfloxacin-loaded solid lipid nanoparticles integrated with microneedles for the treatment of biofilm-infected wounds. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115181

Vancouver

Chen J, Wu W, Feng B, Ning M, Cai Z, Zhang Q, et al. Formulation development and optimization of sparfloxacin-loaded solid lipid nanoparticles integrated with microneedles for the treatment of biofilm-infected wounds. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115181

BibTeX
@article{Chen2026,
  author = {Chen, Jianmin and Wu, Wanhui and Feng, Baozhu and Ning, Meilian and Cai, Ziyan and Zhang, Qiulong and Du, Liyang and Gao, Yunhua},
  title = {Formulation development and optimization of sparfloxacin-loaded solid lipid nanoparticles integrated with microneedles for the treatment of biofilm-infected wounds},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  doi = {10.1016/j.ejpb.2026.115181}
}
Kostenlos starten →